Categories: News

Due to Strong Demand, Token Cat Limited Announced the Signing of a $1 Billion Cross-border Sales Cooperation Agreement with Ouyi Industrial CO.,Limited.

BEIJING, Nov. 20, 2025 /PRNewswire/ — Token Cat Limited (Nasdaq: TC, hereinafter referred to as the “Company”) today announced that it has signed a strategic cooperation framework agreement with Ouyi Industrial CO.,Limited (“Ouyi”). The two parties will jointly build a cross-border supply chain cloud platform to further expand the company’s business footprint in the global market. According to the plan of both parties, this cooperation is expected to achieve a cumulative overseas sales amount of $1 billion within the next three years.

- Advertisement -

This cooperation aims to integrate the core advantages of both parties in supply chain, product resources and international markets. The Company will give full play to its supply capacity in the aftermarket parts of passenger cars and the product portfolio of automotive sales, accessories sales and automotive services; Ouyi relying on its mature overseas channel system, international trade operation experience and local market execution capabilities, will help the Company accelerate its entry into high-growth markets around the world.

- Advertisement -

The two parties plan to realize the full-link digital management from product display, collaborative sales, cross-border logistics, warehouse and distribution management to after-sales support through the cross-border supply chain cloud platform. In the future, the platform will also become a global delivery channel for the Company’s new business modules, including potential vehicle exports, key components of electric vehicles, and other business lines that the Company may acquire or integrate in the future.

- Advertisement -

This cooperation strengthens the Company’s pillars of capitalization, digitization, and globalization, boosting international revenue and profitability. Both parties expect improved platform efficiency and product optimization to enhance global competitiveness and support sustainable growth.

- Advertisement -

Safe Harbor Statement

- Advertisement -

This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and the U.S. Private Securities Litigation Reform Act of 1995. These statements, including those regarding the Company’s plans and outlook, are identified by terms such as “may,” “will,” “expect,” “anticipate,” “believe,” and similar expressions. They are based on current expectations and market conditions and involve risks and uncertainties beyond the Company’s control. More information on these risks is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements except as required by law.

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/due-to-strong-demand-token-cat-limited-announced-the-signing-of-a-1-billion-cross-border-sales-cooperation-agreement-with-ouyi-industrial-colimited-302621707.html

- Advertisement -

Recent Posts

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

1 hour ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

1 hour ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

1 hour ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

1 hour ago